TD Waterhouse Canada Inc. Acquires 74,905 Shares of Danaher Corporation $DHR

TD Waterhouse Canada Inc. boosted its holdings in Danaher Corporation (NYSE:DHR) by 120.8% during the third quarter, HoldingsChannel.com reports. The fund owned 136,920 shares of the conglomerate’s stock after purchasing an additional 74,905 shares during the period. TD Waterhouse Canada Inc.’s holdings in Danaher were worth $30,335,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the business. BlackRock Inc. bought a new position in Danaher during the second quarter worth about $10,492,520,000. Wellington Management Group LLP boosted its holdings in Danaher by 10.4% during the second quarter. Wellington Management Group LLP now owns 16,316,834 shares of the conglomerate’s stock valued at $3,108,031,000 after purchasing an additional 1,542,310 shares in the last quarter. Jupiter Topco LLC acquired a new stake in Danaher during the second quarter valued at approximately $1,456,317,000. Generation Investment Management LLP bought a new stake in shares of Danaher in the 2nd quarter valued at approximately $1,287,949,000. Finally, Bank of America Corp DE bought a new stake in shares of Danaher in the 2nd quarter valued at approximately $993,846,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Price Performance

Shares of Danaher stock opened at $228.87 on Friday. The stock has a market capitalization of $160.89 billion, a price-to-earnings ratio of 40.65, a P/E/G ratio of 2.88 and a beta of 0.76. The firm’s 50-day moving average price is $214.04 and its two-hundred day moving average price is $195.97. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80.

Danaher (NYSE:DHR) last posted its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The company had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. During the same quarter in the previous year, the company posted $0.77 earnings per share. Danaher’s quarterly revenue was up 5.5% compared to the same quarter last year. On average, equities analysts predict that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be given a dividend of $0.40 per share. The ex-dividend date is Wednesday, September 30th. This represents a $1.60 dividend on an annualized basis and a yield of 0.7%. Danaher’s dividend payout ratio is 28.42%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on the company. Wall Street Zen cut Danaher from a “buy” rating to a “hold” rating in a report on Sunday. Evercore restated an “outperform” rating and set a $230.00 target price on shares of Danaher in a research report on Monday, July 6th. Guggenheim boosted their price target on Danaher from $200.00 to $250.00 and gave the company a “buy” rating in a research note on Thursday, October 1st. The Goldman Sachs Group upped their price target on Danaher from $210.00 to $250.00 and gave the company a “buy” rating in a research report on Monday, September 21st. Finally, UBS Group assumed coverage on Danaher in a research report on Wednesday, September 9th. They issued a “buy” rating and a $250.00 price target on the stock. Two research analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $235.41.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.

The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.